Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding
- Status
- COMPLETED
- Phase
- PHASE2
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)
- Status
- COMPLETED
- Phase
- PHASE2
Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tumor RNA Transfected Dendritic Cell Vaccines
- Status
- COMPLETED
- Phase
- PHASE1
A Research Study for Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE4
Vaccine Treatment for Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
The Plenaxis® Experience Study
- Status
- SUSPENDED
- Phase
- PHASE4